97 related articles for article (PubMed ID: 1316943)
1. Detection of human serum antibodies that neutralize infectious human papillomavirus type 11 virions.
Christensen ND; Kreider JW; Shah KV; Rando RF
J Gen Virol; 1992 May; 73 ( Pt 5)():1261-7. PubMed ID: 1316943
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus (HPV) type 11 recombinant virus-like particles induce the formation of neutralizing antibodies and detect HPV-specific antibodies in human sera.
Rose RC; Reichman RC; Bonnez W
J Gen Virol; 1994 Aug; 75 ( Pt 8)():2075-9. PubMed ID: 8046412
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibody-mediated neutralization of infectious human papillomavirus type 11.
Christensen ND; Kreider JW; Cladel NM; Patrick SD; Welsh PA
J Virol; 1990 Nov; 64(11):5678-81. PubMed ID: 2170694
[TBL] [Abstract][Full Text] [Related]
4. Use of human papillomavirus type 11 virions in an ELISA to detect specific antibodies in humans with condylomata acuminata.
Bonnez W; Da Rin C; Rose RC; Reichman RC
J Gen Virol; 1991 Jun; 72 ( Pt 6)():1343-7. PubMed ID: 1646276
[TBL] [Abstract][Full Text] [Related]
5. Incidence of antibodies to human papillomavirus type 1 in patients with cutaneous and mucosal papillomas.
Viac J; Chomel JJ; Chardonnet Y; Aymard M
J Med Virol; 1990 Sep; 32(1):18-21. PubMed ID: 2173734
[TBL] [Abstract][Full Text] [Related]
6. Neutralization of human papillomavirus (HPV) pseudovirions: a novel and efficient approach to detect and characterize HPV neutralizing antibodies.
Yeager MD; Aste-Amezaga M; Brown DR; Martin MM; Shah MJ; Cook JC; Christensen ND; Ackerson C; Lowe RS; Smith JF; Keller P; Jansen KU
Virology; 2000 Dec; 278(2):570-7. PubMed ID: 11118379
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus type 11 neutralization in the athymic mouse xenograft system: correlation with virus-like particle IgG concentration.
Bryan JT; Jansen KU; Lowe RS; Fife KH; McClowry T; Glass D; Brown DR
J Med Virol; 1997 Nov; 53(3):185-8. PubMed ID: 9365880
[TBL] [Abstract][Full Text] [Related]
8. Detection of serologic neutralizing antibodies against HPV-11 in patients with condyloma acuminata and cervical dysplasia using an in vitro assay.
Leiserowitz GS; Hall KS; Foster CA; Hitchcock ME; Christensen ND; Heim K; Smith LH
Gynecol Oncol; 1997 Aug; 66(2):295-9. PubMed ID: 9264579
[TBL] [Abstract][Full Text] [Related]
9. Antibody-mediated neutralization in vivo of infectious papillomaviruses.
Christensen ND; Kreider JW
J Virol; 1990 Jul; 64(7):3151-6. PubMed ID: 1693698
[TBL] [Abstract][Full Text] [Related]
10. Immunological cross-reactivity to laboratory-produced HPV-11 virions of polysera raised against bacterially derived fusion proteins and synthetic peptides of HPV-6b and HPV-16 capsid proteins.
Christensen ND; Kreider JW; Cladel NM; Galloway DA
Virology; 1990 Mar; 175(1):1-9. PubMed ID: 2155503
[TBL] [Abstract][Full Text] [Related]
11. Postattachment neutralization of papillomaviruses by monoclonal and polyclonal antibodies.
Christensen ND; Cladel NM; Reed CA
Virology; 1995 Feb; 207(1):136-42. PubMed ID: 7871722
[TBL] [Abstract][Full Text] [Related]
12. Spontaneously regressing oral papillomas induce systemic antibodies that neutralize canine oral papillomavirus.
Ghim S; Newsome J; Bell J; Sundberg JP; Schlegel R; Jenson AB
Exp Mol Pathol; 2000 Jun; 68(3):147-51. PubMed ID: 10816383
[TBL] [Abstract][Full Text] [Related]
13. Synthetic peptides derived from E7 region of human papillomavirus type 16 used as antigens in ELISA.
Krchnák V; Vágner J; Suchánková A; Krcmár M; Ritterová L; Vonka V
J Gen Virol; 1990 Nov; 71 ( Pt 11)():2719-24. PubMed ID: 2174961
[TBL] [Abstract][Full Text] [Related]
14. [Specific antigens of the papillomavirus group in various intra-epithelial proliferations. Methods of detection].
Gogusev J; Bigel P; Le Pelletier O; Crespeau N; Nezelof C
Pathol Biol (Paris); 1986 Sep; 34(7):835-40. PubMed ID: 2431375
[TBL] [Abstract][Full Text] [Related]
15. Induction of neutralizing antibodies to papillomaviruses by anti-idiotypic antibodies.
Christensen ND; Reed CA; Cladel NM
Virology; 1995 Jul; 210(2):292-301. PubMed ID: 7542415
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus types 6 and 11 have antigenically distinct strongly immunogenic conformationally dependent neutralizing epitopes.
Christensen ND; Kirnbauer R; Schiller JT; Ghim SJ; Schlegel R; Jenson AB; Kreider JW
Virology; 1994 Nov; 205(1):329-35. PubMed ID: 7526536
[TBL] [Abstract][Full Text] [Related]
17. Evidence for the presence of neutralizing antibodies against human papillomavirus type 6 in infants born to mothers with condyloma acuminata.
Kawana K; Yasugi T; Yoshikawa H; Kawana Y; Matsumoto K; Nakagawa S; Onda T; Kikuchi A; Fujii T; Kanda T; Taketani Y
Am J Perinatol; 2003 Jan; 20(1):11-6. PubMed ID: 12638076
[TBL] [Abstract][Full Text] [Related]
18. Presence of antibody reactive with synthetic peptide derived from L2 open reading frame of human papillomavirus types 6b and 11 in human sera.
Suchánková A; Ritter O; Hirsch I; Krchnák V; Kalos Z; Hamsíková E; Brichácek B; Vonka V
Acta Virol; 1990 Sep; 34(5):433-42. PubMed ID: 1705748
[TBL] [Abstract][Full Text] [Related]
19. Neutralization of human papillomavirus type 11 (HPV-11) by serum from women vaccinated with yeast-derived HPV-11 L1 virus-like particles: correlation with competitive radioimmunoassay titer.
Brown DR; Bryan JT; Schroeder JM; Robinson TS; Fife KH; Wheeler CM; Barr E; Smith PR; Chiacchierini L; DiCello A; Jansen KU
J Infect Dis; 2001 Nov; 184(9):1183-6. PubMed ID: 11598842
[TBL] [Abstract][Full Text] [Related]
20. A human papillomavirus related to human papillomavirus MM7/LVX82 produces distinct histological abnormalities in human foreskin implants grown as athymic mouse xenografts.
Brown DR; McClowry TL; Bryan JT; Stoler M; Schroeder-Diedrich JM; Fife KH
Virology; 1998 Sep; 249(1):150-9. PubMed ID: 9740786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
